E-LIB Suche - Ergebnisse für: Cortellini, A

1

96P Induction chemotherapy backbone in frail patients (pts)..:

Vendittelli, A. ; Fiorenti, M. ; Mingo, E.C....
ESMO Open. 9 (2024) - p. 102675 , 2024

Link: https://doi.org/10.1016/..

2

112P Measuring time-toxicity and prognostic impact of hospi..:

Awosika, N.O. ; Maleki, A. ; Mehan, A....
ESMO Open. 9 (2024) - p. 102337 , 2024

Link: https://doi.org/10.1016/..

3

Glycemic control and cancer outcomes in oncologic patients ..:

Natalicchio, A. ; Marrano, N. ; Montagnani, M....
Journal of Endocrinological Investigation. , 2024

Link: https://doi.org/10.1007/..

4

T.07.3: CHARACTERISTICS AND OUTCOMES OF IMMUNOTHERAPYRELATE..:

Celsa, C. ; Cabibbo, G. ; Fulgenzi, C.A.M....
Digestive and Liver Disease. 56 (2024) - p. S255 , 2024

Link: https://doi.org/10.1016/..

5

111P Characteristics and outcomes of immunotherapy-related ..:

Celsa, C. ; Cabibbo, G. ; Marron, T.U....
Immuno-Oncology and Technology. 20 (2023) - p. 100583 , 2023

Link: https://doi.org/10.1016/..

6

96P The Hammersmith score optimises patient selection and p..:

Korolewicz, J.A. ; Scheiner, B. ; Fulgenzi, C....
ESMO Open. 8 (2023) 1 - p. 100954 , 2023

Link: https://doi.org/10.1016/..

7

Circulating Tumor DNA (ctDNA) Dynamics and Clinical Outcome..:

Ghidini, M. ; Hahne, J. Claus ; Senti, C....
The Journal of Liquid Biopsy. 1 (2023) - p. 100029 , 2023

Link: https://doi.org/10.1016/..

8

Implementation of a customized treatment protocol, based on..:

Pavan, A. ; Germanotta, M. ; Cortellini, L....
Gait & Posture. 105 (2023) - p. S34-S35 , 2023

Link: https://doi.org/10.1016/..

9

Learning lessons from the COVID-19 pandemic for real-world ..:

Castelo-Branco, L. ; Lee, R. ; Brandão, M....
ESMO Open. 8 (2023) 4 - p. 101596 , 2023

Link: https://doi.org/10.1016/..

10

Erratum to 'Evaluation of COVID-19 impact on DELAYing diagn..:

Cantini, L. ; Mentrasti, G. ; Lo Russo, G....
ESMO Open. 7 (2022) 2 - p. 100471 , 2022

Link: https://doi.org/10.1016/..

11

EP08.01-043 Clinicopathologic and Genomic Factors Impacting..:

Alessi, J. ; Elkrief, A. ; Ricciuti, B....
Journal of Thoracic Oncology. 17 (2022) 9 - p. S358-S359 , 2022

Link: https://doi.org/10.1016/..

12

64P Safety and efficacy of immune checkpoint inhibitors (IC..:

Nassar, A.H. ; Zarif, T. ; Abou Alaiwi, S....
Immuno-Oncology and Technology. 16 (2022) - p. 100169 , 2022

Link: https://doi.org/10.1016/..

13

237P Immune checkpoint inhibitor therapy and outcomes from ..:

Cortellini, A. ; Dettorre, G. ; Dafni, U....
Immuno-Oncology and Technology. 16 (2022) - p. 100226 , 2022

Link: https://doi.org/10.1016/..

14

Evaluation of COVID-19 impact on DELAYing diagnostic-therap..:

Cantini, L. ; Mentrasti, G. ; Russo, G.L....
ESMO Open. 7 (2022) 2 - p. 100406 , 2022

Link: https://doi.org/10.1016/..

15

Clinical determinants of complete response to vismodegib in..:

Fargnoli, M.C. ; Pellegrini, C. ; Piccerillo, A....
Journal of the European Academy of Dermatology and Venereology. 35 (2021) 12 - p. , 2021

Link: https://doi.org/10.1111/..